drugset / Trial / NCT07797946

Preoperative Ivabradine Doses for Hemodynamic Stability in FESS

NCT07797946 ↗

Not yet recruiting 60 enrolled Minia University
RandomizedParallel-groupQuadruple-blindPrevention

Summary

This study compares two different preoperative doses of a heart-rate-lowering medication called ivabradine in patients undergoing endoscopic sinus surgery under general anesthesia. Patients will receive either a lower dose, a higher dose, or a placebo (inactive pill) before surgery. The goal is to see which approach best keeps blood pressure and heart rate stable during surgery, and whether it reduces bleeding and improves the surge

Timeline

Start
2026-08-01
Primary completion
2027-02-01
Completion
2027-02-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Ivabradine Small molecule 5 mg Oral
Subject Ivabradine Small molecule 7.5 mg Oral

Indications

No indication recorded.